Despite a few promising outcomes, cell delivery has encountered crucial barriers in therapeutic translation, including immune rejection, pathogen transmission, potential tumorigenesis, and regulatory difficulties.
Efficiency and power depend on sample size, sampling fractions within each stratum × outcome cell, distributional assumptions and the regression model.
Among the significant genes that show a high expression in tumours with unfavourable outcome, cell cycle associated genes can be found (E2F1, CCNA2, CCNB1, KIFC1).
To gain a deeper understanding of the reaction outcome, cell viability was assessed by analyzing CFU on agar plates containing rich medium throughout the reaction (Fig. 4b).
Two models for the outcomes of cell-in-cell are suggested, in which heterotypic cell-in-cell formation is defined as an 'in-cell' danger signal.
Many factors influence screen outcomes, including cell line selection, screen format, type of reagent, coverage of genes by the reagent library, cell assay, and screen data analysis.
The resulting growth data represents the net outcome of cell proliferation and cell death.
In conclusion, our data establish that autophagy can have a differential outcome on cell death or cell survival.
Altogether, this multi-step screening process may significantly improve clinical outcomes of cell-based therapies.
These results highlight the ability to exogenously and noninvasively control and refine therapeutic outcomes following cell transplantation.
